Cafepharma Today

Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen
Biopharma prepares to pivot from China as Biosecure Act advances
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Yahoo/Zacks.com
Thursday, December 18, 2008 - 3:35pm
Bizjournals.com
Thursday, December 18, 2008 - 3:34pm
tags:
Reuters
Thursday, December 18, 2008 - 9:27am
tags:
WSJ Online
Thursday, December 18, 2008 - 9:24am
tags:
Fierce Biotech
Thursday, December 18, 2008 - 8:18am
tags:
Pharmalot
Thursday, December 18, 2008 - 8:13am
Pharmalot
Thursday, December 18, 2008 - 8:11am
Seeking Alpha
Thursday, December 18, 2008 - 7:17am
InVivo
Wednesday, December 17, 2008 - 5:12pm
tags:
Bizjournals.com
Wednesday, December 17, 2008 - 4:45pm
Yahoo/Zacks.com
Wednesday, December 17, 2008 - 10:00am
Fierce Pharma
Wednesday, December 17, 2008 - 9:51am
tags:
TheStreet.com
Wednesday, December 17, 2008 - 8:43am
FT.com
Wednesday, December 17, 2008 - 8:41am

Pages

Latest Jobs

Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Miami, Florida, 33222
PV8 US Innovex Inc.
Tampa, Florida, 33646
Hanger Clinic
Burbank, California, 91520
Vanda Pharmaceuticals
Grand Rapids, Michigan, 49528
Amplity Health
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Baton Rouge, Louisiana, 70873
Woman's Hospital
Asheville, North Carolina, 28814
Sanofi
Fields, Oregon, 97710
CSL Behring
Huntsville, Alabama, 35824
Bausch Health

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.